Results 221 to 230 of about 37,508 (242)
Some of the next articles are maybe not open access.
Tolerability and Safety of Sustained-Release Bupropion in the Management of Smoking Cessation
Drugs, 2012Henri-Jean Aubin
exaly
Bupropion: pharmacology and therapeutic applications
Expert Review of Neurotherapeutics, 2006Kevin F Foley, Richard E Kast
exaly
Bupropion occupancy of the dopamine transporter is low during clinical treatment
Psychopharmacology, 2002Jeffrey H Meyer +2 more
exaly
CYP2B6 Genotype Alters Abstinence Rates in a Bupropion Smoking Cessation Trial
Biological Psychiatry, 2007Christopher Jepson +2 more
exaly
Stereoselective Metabolism of Bupropion by Cytochrome P4502B6 (CYP2B6) and Human Liver Microsomes
Pharmaceutical Research, 2008Evan D Kharasch
exaly
Pharmacokinetic Optimisation of Sustained-Release Bupropion for Smoking Cessation
Drugs, 2012J Andrew Johnston
exaly
A placebo controlled trial of bupropion for smoking cessation in schizophrenia
Biological Psychiatry, 2002Tony P George +2 more
exaly
Bupropion SR vs. Placebo for Weight Loss in Obese Patients with Depressive Symptoms
Obesity, 2002Kishore M Gadde +2 more
exaly
Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant
Therapeutic Advances in Psychopharmacology, 2016Krisna Patel +2 more
exaly